mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
-0.39 |
0.003 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.003 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.005 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.005 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.005 |